ReShape Lifesciences Inc expected to post a loss of $1.79 a share - Earnings Preview

Vyome Holdings

05/08/2023 01:17

* ReShape Lifesciences Inc  RSLS.OQ   RSLS.O  is expected
to show
a fall in quarterly revenue when it reports  results on August
7. 
    * The San Clemente California-based  company is expected to
report
 a 9.8% decrease in revenue to $2.61 million from $2.89 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ReShape
Lifesciences Inc
is for a loss of $1.79 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $8​, above​ its last closing price of $1.45.
​​​

This summary was machine generated August 5 at 00:17 GMT.  All
figures in US dollars  unless otherwise stated